Treatment Education for Perinatal Women and Their Community Support

Johns Hopkins University

Status: Begins enrollment in 4 months

Conditions: Opioid Dependency

Treatments: Other: substance abuse treatment education

Study type: Interventional

Funder types: Other

Identifiers

NCT06733649

IRB00478467

Details and patient eligibility

About

The study evaluates the feasibility and acceptability of a 50 minute treatment education session for perinatal women with opioid use disorder and a community support person. The education session provides correct information about opioid agonist medications and neonatal abstinence syndrome.

Full description

Perinatal women with opioid disorder often face criticism by social network members for receiving opioid agonist treatment. Feeling stigmatized by others may impact willingness to start and remain in agonist treatment.

The present study evaluates the feasibility and acceptability of a 50 minute treatment education session for perinatal women who are treated using an agonist medication (methadone or buprenorphine) and community support chosen by the patient.

Study participants will be recruited from perinatal women who receive substance abuse treatment at the Center for Addiction and Pregnancy or Addiction Treatment Services at Johns Hopkins Bayview campus. These women will work with a counselor to select a community support person to bring to the program for the education session.

The session will provide correct information on opioid agonist medications and neonatal abstinence syndrome. This session will follow a structured outline.

Enrollment: 80 estimated patients

Sex: All

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• perinatal women treated with agonist medication
• interest in study participation
• interest in community support:
• interest in study participation

Exclusion criteria

• perinatal women not treated with agonist medication
• not interested in study participation
• not interested in community support:
• not interested in study participation

Trial design

Primary purpose: Supportive Care

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

80 participants in 1 patient group

Treatment education for perinatal women and the womens' community support

Experimental group

Treatment:

Other: substance abuse treatment education